These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 7956623)
1. Apolipoprotein A-IV levels and phenotype distribution in NIDDM. Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623 [TBL] [Abstract][Full Text] [Related]
2. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-IV in diabetes mellitus. Verges B Diabete Metab; 1995 Apr; 21(2):99-105. PubMed ID: 7621979 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease. Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502 [TBL] [Abstract][Full Text] [Related]
5. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Rewers M; Kamboh MI; Hoag S; Shetterly SM; Ferrell RE; Hamman RF Diabetes; 1994 Dec; 43(12):1485-9. PubMed ID: 7958503 [TBL] [Abstract][Full Text] [Related]
6. Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus. Duvillard L; Pont F; Florentin E; Gambert P; Vergès B Atherosclerosis; 2000 Sep; 152(1):229-37. PubMed ID: 10996359 [TBL] [Abstract][Full Text] [Related]
7. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin. Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141 [TBL] [Abstract][Full Text] [Related]
8. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Frénais R; Ouguerram K; Maugeais C; Mahot P; Maugère P; Krempf M; Magot T Diabetologia; 1997 May; 40(5):578-83. PubMed ID: 9165227 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-IV polymorphism in Saami and Finns: frequency and effect on serum lipid levels. Lehtinen S; Luoma P; Näyhä S; Hassi J; Ehnholm C; Nikkari T; Peltonen N; Jokela H; Koivula T; Lehtimäki T Ann Med; 1998 Apr; 30(2):218-23. PubMed ID: 9667802 [TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study. Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486 [TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels. Kim JY; Kim OY; Paik JK; Lee SH; Lee JH J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427 [TBL] [Abstract][Full Text] [Related]
12. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects. Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493 [TBL] [Abstract][Full Text] [Related]
13. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. Golay A; Zech L; Shi MZ; Chiou YA; Reaven GM; Chen YD J Clin Endocrinol Metab; 1987 Sep; 65(3):512-8. PubMed ID: 3114304 [TBL] [Abstract][Full Text] [Related]
14. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179 [TBL] [Abstract][Full Text] [Related]
16. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men. Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Falko JM; Parr JH; Simpson RN; Wynn V Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053 [TBL] [Abstract][Full Text] [Related]
18. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity. Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191 [TBL] [Abstract][Full Text] [Related]
19. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control. Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858 [TBL] [Abstract][Full Text] [Related]
20. Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0). Tilly-Kiesi M; Lichtenstein AH; Rintarahko J; Taskinen MR Atherosclerosis; 1998 Mar; 137(1):37-47. PubMed ID: 9568735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]